The document is a review by Dr. Trupti Chitre that explores pyrimidine pharmacophores as thymidine monophosphate kinase inhibitors for antitubercular activity. It highlights the urgent need for new antitubercular agents due to the rise of drug-resistant tuberculosis strains. The review emphasizes structure-activity relationship studies and computational analyses of nucleotide and nucleoside derivatives of pyrimidine analogs as potential TMPKMT inhibitors.